Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Plasma TGF-β₁ in pediatric cystic fibrosis: potential biomarker of lung disease and response to therapy.

Pediatric pulmonology - 1 Jul 2011

Harris William T, Muhlebach Marianne S, Oster Robert A, Knowles Michael R, Clancy J P, Noah Terry L

Abstract excerpt

INTRODUCTION: Transforming growth factor beta-1 (TGF-β₁) is an important genetic modifier of lung disease severity in cystic fibrosis (CF), yet the mechanism behind this disease association remains unknown. Initial steps in the investigation of the relationship between TGF-β₁ and CF lung disease include determining the most appropriate available biospecimen for TGF-β₁ protein measurement. HYPOTHESIS: In...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Bacterial Agents
Share to Bronchoalveolar Lavage

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cystic Fibrosis

Share to Enzyme-Linked Immunosorbent Assay

Share to Pseudomonas aeruginosa

Share to Pseudomonas Infections

Share to Respiratory Function Tests

Share to Transforming Growth Factor beta1

Source

Open in PubMed Open full text

Identifiers

PMID: 21337732
DOI: 10.1002/ppul.21430
PMCID: PMC3115503

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Plasma TGF-β₁ in pediatric cystic fibrosis: potential biomarker of lung disease and response to therapy.PMID 21337732Read ↗

Association of Serum TGF-β1 Levels with Different Clinical Phenotypes of Cystic Fibrosis Exacerbation.Semantic proximity Read ↗

The Effect of TGF-β1 Polymorphisms on Pulmonary Disease Progression in Patients with Cystic FibrosisSemantic proximity Read ↗

The effect of TGF-β1 polymorphisms on pulmonary disease progression in patients with cystic fibrosis.Semantic proximity Read ↗

Transforming growth factor β1 genotypes in relation to TGFβ1, interleukin-8, and tumor necrosis factor alpha in induced sputum and blood in cystic fibrosis.Semantic proximity Read ↗

The effect of TGF-beta1 polymorphisms on pulmonary disease progression in patients with cystic fibrosisSemantic proximity Read ↗

Inflammatory Responses to Individual Microorganisms in the Lungs of Children With Cystic FibrosisSemantic proximity Read ↗

Cytokine gene polymorphisms and severity of CF lung disease.Semantic proximity Read ↗

Elevated plasma TGF-beta1 levels in patients with chronic obstructive pulmonary disease.Semantic proximity Read ↗

TGF-beta(1) genotype and accelerated decline in lung function of patients with cystic fibrosis.Semantic proximity Read ↗

Macrophage migration inhibitory factor enzymatic activity, lung inflammation, and cystic fibrosis.Semantic proximity Read ↗

Steady-State Therapy with Azithromycin or Low-Dose Prednisolone in Paediatric Cystic Fibrosis Patients: Inflammatory Markers and Disease Progression.Semantic proximity Read ↗

New microbicidal functions of tracheal glands: defective anti-infectious response to Pseudomonas aeruginosa in cystic fibrosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.